Benzoxonium chloride

This classification denotes an anti-infective agent with the molecular formula C23H42NO2.Cl, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 12IMO9R11X, chemically known as n-dodecyl-n,n-bis(2-hydroxyethyl)benzenemethanaminium chloride but generally known as benzoxonium chloride, which bears US NIH Compound Identifier 29563. European Medicines Agency schedules Benzoxonium chloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05764MIG. The term BENZOXONIUM CHLORIDE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules benzoxonium chloride in its Anatomical Therapeutic Chemical (ATC) Classification. Most nations schedule benzoxonium chloride under HS 29239000 and SITC 51481. As of Q4 2014, BENZOXONIUM CHLORIDE remains the US FDA Preferred Term for this commodity. Benzoxonium chloride bears US NLM identifiers UMLS ID C0105668 and NCI Concept Code C73251. SMILES: Cl.OCC[N](CCCCCCCCCCCC)(CCO)Cc1ccccc1.